Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


LC/MS Fundamentals and Applications

21 May 2013 - 27 Jun 2013 - Live-on-the-Web



Bookmark and Share


This comprehensive overview course provides relevant, practical approaches that you can immediately apply in the lab.  We cover some mass spectrometry and LC interface theory, however, the real focus is on improving your ability to use LC/MS on a daily basis.

 

Who Should Attend: Researchers, practitioners, technicians and others who are currently using or plan to use LC, LC/MS, or data produced by LC/MS.

 

This Live-on-the-web format covers 3 days of instruction over a 6 week period. The class meets over the internet twice a week for approximately 90 minutes per session and each session is recorded. This course is also available in Self-Paced and classroom formats.  This course may also be customized for in-house presentation at your facility. Click here to learn more.  Register now!

 

How You’ll Benefit:

·         Understand LC, MS and LC/MS interface operational fundamentals

·         Receive an LC/MS applications overview for pharma, biotech, chemical, forensic and toxicology

·         Learn how to modify and optimize HPLC methods for LC/MS

·         See how to use LC/MS to obtain qualitative information about your samples



Further information
Scientific News
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!